NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Virtu Financial, Inc. (NASDAQ: VIRT ), Littelfuse, Inc. (NASDAQ: LFUS ), Gogo Inc. (NASDAQ: GOGO ), Brookfield Asset Management Inc. (NYSE: BAM ), Protalix BioTherapeutics, Inc. (NYSE: PLX ), and Halozyme Therapeutics, Inc. (NASDAQ: HALO ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
VIRT DOWNLOAD: http://Fundamental-Markets.com/register/?so=VIRT LFUS DOWNLOAD: http://Fundamental-Markets.com/register/?so=LFUS GOGO DOWNLOAD: http://Fundamental-Markets.com/register/?so=GOGO BAM DOWNLOAD: http://Fundamental-Markets.com/register/?so=BAM PLX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PLX HALO DOWNLOAD: http://Fundamental-Markets.com/register/?so=HALO
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Virtu Financial, Inc. (NASDAQ: VIRT ), Littelfuse, Inc. (NASDAQ: LFUS ), Gogo Inc. (NASDAQ: GOGO ), Brookfield Asset Management Inc. (NYSE: BAM ), Protalix BioTherapeutics, Inc. (NYSE: PLX ), and Halozyme Therapeutics, Inc. (NASDAQ: HALO ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 11th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
VIRTU FINANCIAL, INC. (VIRT) REPORT OVERVIEW
Virtu Financial's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Virtu Financial reported revenue of $815.05MM vs $147.29MM (up 453.38%) and basic earnings per share $1.89 vs $0.10 (up 1,790.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Virtu Financial reported revenue of $1,027.98MM vs $702.27MM (up 46.38%) and basic earnings per share $0.03 vs $0.83 (down 96.39%). Virtu Financial is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $2.22 and is expected to report on February 14th, 2019.
To read the full Virtu Financial, Inc. (VIRT) report, download it here: http://Fundamental-Markets.com/register/?so=VIRT
-----------------------------------------
LITTELFUSE, INC. (LFUS) REPORT OVERVIEW
Littelfuse's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Littelfuse reported revenue of $417.81MM vs $285.44MM (up 46.37%) and basic earnings per share $1.48 vs $1.71 (down 13.45%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Littelfuse reported revenue of $1,221.53MM vs $1,056.16MM (up 15.66%) and basic earnings per share $5.27 vs $4.63 (up 13.82%). Littelfuse is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $2.10. The estimated EPS forecast for the next fiscal year is $10.57 and is expected to report on January 30th, 2019.
To read the full Littelfuse, Inc. (LFUS) report, download it here: http://Fundamental-Markets.com/register/?so=LFUS
-----------------------------------------
GOGO INC. (GOGO) REPORT OVERVIEW
Gogo's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Gogo reported revenue of $231.83MM vs $165.41MM (up 40.16%) and basic earnings per share -$0.34 vs -$0.52. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Gogo reported revenue of $699.09MM vs $596.55MM (up 17.19%) and basic earnings per share -$2.17 vs -$1.58. Gogo is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.56. The estimated EPS forecast for the next fiscal year is -$1.98 and is expected to report on February 28th, 2019.
To read the full Gogo Inc. (GOGO) report, download it here: http://Fundamental-Markets.com/register/?so=GOGO
-----------------------------------------
BROOKFIELD ASSET MANAGEMENT INC. (BAM) REPORT OVERVIEW
Brookfield Asset Management's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Brookfield Asset Management reported revenue of $12,631.00MM vs $6,001.00MM (up 110.48%) and basic earnings per share $0.84 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Brookfield Asset Management reported revenue of $40,786.00MM vs $24,411.00MM (up 67.08%) and basic earnings per share $1.37 vs $1.58 (down 13.29%). Brookfield Asset Management is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018.
To read the full Brookfield Asset Management Inc. (BAM) report, download it here: http://Fundamental-Markets.com/register/?so=BAM
-----------------------------------------
PROTALIX BIOTHERAPEUTICS, INC. (PLX) REPORT OVERVIEW
Protalix BioTherapeutics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Protalix BioTherapeutics reported revenue of $4.55MM vs $2.89MM (up 57.60%) and basic earnings per share -$0.06 vs -$0.48. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Protalix BioTherapeutics reported revenue of $19.24MM vs $9.20MM (up 109.17%) and basic earnings per share -$0.65 vs -$0.29. Protalix BioTherapeutics is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is -$0.07 and is expected to report on March 5th, 2019.
To read the full Protalix BioTherapeutics, Inc. (PLX) report, download it here: http://Fundamental-Markets.com/register/?so=PLX
-----------------------------------------
HALOZYME THERAPEUTICS, INC. (HALO) REPORT OVERVIEW
Halozyme Therapeutics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Halozyme Therapeutics reported revenue of $30.87MM vs $29.57MM (up 4.41%) and basic earnings per share -$0.19 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Halozyme Therapeutics reported revenue of $316.61MM vs $146.69MM (up 115.84%) and basic earnings per share $0.46 vs -$0.81. Halozyme Therapeutics is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.23. The estimated EPS forecast for the next fiscal year is -$0.64 and is expected to report on February 19th, 2019.
To read the full Halozyme Therapeutics, Inc. (HALO) report, download it here: http://Fundamental-Markets.com/register/?so=HALO
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
